There are certain phrases that Wachuka Gichohi finds difficult to hear after enduring four years of living with long COVID, ...
No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...
Khaleej Times on MSN2h
UAE: Feeling under the weather? Doctors warn it could be 'walking pneumonia'A 50-year-old patient consulted doctors at a private hospital in Abu Dhabi with a persistent dry cough and low-grade fever ...
Medpage Today on MSN13h
Primary Biliary Cholangitis Incidence and Prevalence GrowingPrimary biliary cholangitis (PBC) has typically been considered a rare condition, with a pooled global estimated incidence of ...
REM stands for rapid eye movement — a stage in the sleep cycle when your brain is almost as active as when you’re awake.
Yael Goverover has worked to understand the cognitive symptoms of MS and acquired brain injury, and their impact on ...
Medpage Today on MSN8h
MEK Inhibitor Scores Big Win in Adults, Children With Neurofibromatosis Type 1Almost half of adults and children with neurofibromatosis type 1 (NF1) responded to the investigational MEK inhibitor ...
Blueprint Medicines' AYVAKIT leads its revenue growth, while its pipeline targets multiple cancers. Read why BPMC stock is a ...
Inovio Pharmaceuticals (NASDAQ: INO) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET ...
Medpage Today on MSN23h
Managing Primary Biliary Cholangitis Progression and SymptomsOnce clinical suspicion has been established for primary biliary cholangitis (PBC), the "serologic hallmark" of the ...
Gilead Sciences, Inc. today announced data from a two-and-a-half-year interim analysis from the ongoing Phase 3 ASSURE study, which showed that 81% (30 out of 37) of participants with primary biliary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback